Toth Financial Advisory Corp Abbott Laboratories Transaction History

Toth Financial Advisory Corp

$825 Million
Q3 2024

A detailed history of Toth Financial Advisory Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Toth Financial Advisory Corp holds 95,886 shares of ABT stock, worth $11.3 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares

95,886

Previous 99,753 3.88%

Holding current value

$11.3 Million

Previous $10.4 Million 5.46%

% of portfolio

1.32%

Previous 1.34%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$100.07 - $118.13 $386,970 - $456,808	-3,867 Reduced 3.88%	95,886 $10.9 Million
Q2 2024 Jul 16, 2024	SELL	$100.73 - $112.44 $170,132 - $189,911	-1,689 Reduced 1.66%	99,753 $10.4 Million
Q1 2024 Apr 16, 2024	SELL	$109.52 - $120.96 $239,410 - $264,418	-2,186 Reduced 2.11%	101,442 $11.5 Million
Q4 2023 Jan 26, 2024	SELL	$90.19 - $110.4 $29,131 - $35,659	-323 Reduced 0.31%	103,628 $11.4 Million
Q3 2023 Oct 12, 2023	SELL	$95.53 - $114.62 $80,531 - $96,624	-843 Reduced 0.8%	103,951 $10.1 Million
Q2 2023 Jul 24, 2023	BUY	$100.78 - $112.29 $108,439 - $120,824	1,076 Added 1.04%	104,794 $11.4 Million
Q1 2023 Apr 24, 2023	SELL	$96.86 - $114.01 $43,102 - $50,734	-445 Reduced 0.43%	103,718 $10.5 Million
Q4 2022 Jan 24, 2023	SELL	$95.06 - $111.52 $292,689 - $343,370	-3,079 Reduced 2.87%	104,163 $0
Q3 2022 Oct 14, 2022	SELL	$96.76 - $112.03 $36,091 - $41,787	-373 Reduced 0.35%	107,242 $10.4 Million
Q2 2022 Jul 25, 2022	SELL	$102.07 - $123.37 $154,840 - $187,152	-1,517 Reduced 1.39%	107,615 $11.7 Million
Q1 2022 Apr 26, 2022	SELL	$114.02 - $139.04 $868,262 - $1.06 Million	-7,615 Reduced 6.52%	109,132 $12.9 Million
Q4 2021 Jan 31, 2022	SELL	$115.53 - $141.46 $359,644 - $440,364	-3,113 Reduced 2.6%	116,747 $16.4 Million
Q3 2021 Oct 20, 2021	SELL	$116.66 - $129.06 $44,214 - $48,913	-379 Reduced 0.32%	119,860 $14.2 Million
Q2 2021 Jul 26, 2021	SELL	$105.79 - $124.53 $62,098 - $73,099	-587 Reduced 0.49%	120,239 $13.9 Million
Q1 2021 Apr 20, 2021	SELL	$108.84 - $128.23 $418,272 - $492,787	-3,843 Reduced 3.08%	120,826 $14.5 Million
Q4 2020 Jan 25, 2021	SELL	$105.0 - $114.42 $638,925 - $696,245	-6,085 Reduced 4.65%	124,669 $13.7 Million
Q3 2020 Oct 16, 2020	SELL	$91.64 - $111.29 $433,640 - $526,624	-4,732 Reduced 3.49%	130,754 $14.2 Million
Q2 2020 Jul 14, 2020	BUY	$76.57 - $98.0 $218,607 - $279,790	2,855 Added 2.15%	135,486 $12.4 Million
Q1 2020 Apr 20, 2020	SELL	$62.82 - $91.86 $105,286 - $153,957	-1,676 Reduced 1.25%	132,631 $10.5 Million
Q4 2019 Jan 27, 2020	SELL	$78.51 - $87.4 $32,581 - $36,271	-415 Reduced 0.31%	134,307 $11.7 Million
Q3 2019 Oct 15, 2019	SELL	$81.84 - $88.74 $109,420 - $118,645	-1,337 Reduced 0.98%	134,722 $11.3 Million
Q2 2019 Jul 17, 2019	BUY	$72.88 - $85.0 $35,128 - $40,970	482 Added 0.36%	136,059 $11.4 Million
Q1 2019 Apr 15, 2019	SELL	$66.22 - $80.06 $254,086 - $307,190	-3,837 Reduced 2.75%	135,577 $10.8 Million
Q4 2018 Jan 22, 2019	SELL	$65.56 - $74.27 $97,159 - $110,068	-1,482 Reduced 1.05%	139,414 $10.1 Million
Q3 2018 Oct 15, 2018	SELL	$60.81 - $73.36 $263,854 - $318,309	-4,339 Reduced 2.99%	140,896 $10.3 Million
Q2 2018 Jul 23, 2018	SELL	$57.57 - $63.54 $10,880 - $12,009	-189 Reduced 0.13%	145,235 $8.86 Million
Q1 2018 Apr 25, 2018	SELL	$56.27 - $63.62 $43,665 - $49,369	-776 Reduced 0.53%	145,424 $8.71 Million
Q4 2017 Feb 06, 2018	SELL	$53.68 - $57.47 $6,656 - $7,126	-124 Reduced 0.08%	146,200 $8.34 Million
Q3 2017 Oct 11, 2017	BUY	$48.06 - $53.64 $7.03 Million - $7.85 Million	146,324	146,324 $7.81 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Toth Financial Advisory Corp with notifications on news.

Account

Toth Financial Advisory Corp Abbott Laboratories Transaction History